The book addresses the connection between dentofacial anomalies and developmental deficiencies closely associated with downstream conditions such as OSA.
G. Dave Singh, DMD, PhD, DDSc, founder and chief medical officer at Vivos Therapeautics Inc, has released a new book to help doctors and dental professionals better understand how to address underlying craniofacial conditions that affect a patient’s overall airway, breathing, and sleep health.
The book, titled Pneumopedics and Craniofacial Epigenetics, covers craniofacial growth and developmental genetics, and addresses the connection between dentofacial anomalies and developmental deficiencies closely associated with downstream conditions such as OSA. The book reportedly further cements the scientific and biological foundation upon which the company’s proprietary approach rests. Vivos, a medical technology company focused on diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, believes this approach, which combines the skills of specially trained dental professionals in cooperation with their medical colleagues, represents the first non-surgical, non-invasive and cost-effective treatment for people with mild-to-moderate obstructive sleep apnea (OSA). By harnessing biomimetic and epigenetic principles, Singh describes not only why this technology works but also how it works.
The book’s foreword was written by Clete Kushida, MD, PhD, division chief and medical director at Stanford Sleep Medicine; neurologist and professor in the department of psychiatry and behavioral sciences at Stanford University Medical Center; and director of the Stanford Center for Human Sleep Research, Stanford University.
“In many respects, this book is the culmination of my life’s work and research, starting with the theoretical foundation set forth in the Spatial Matrix Hypothesis that I first published in 2004 and continuing through the ensuing years with numerous confirmational patient studies in clinical settings,” said Singh, who holds doctorate degrees in dental medicine, orthodontics, and craniofacial development. “Having the opportunity to bring this technology to the world to help patients who are suffering continues to be my mission, and the overarching goal with this book is to spread the word far and wide about how this technology can truly make a difference in how we approach thinking about and treating downstream health conditions like OSA moving forward.”
Singh is a professor and researcher in the sleep medicine field. He has published over 200 articles in peer-reviewed medical, dental, and orthodontic literature, as well as seven books/chapters. His research led to the development of the patented DNA appliance and mRNA appliance technology, now owned and distributed by Vivos.